Browsing: Business

Switzerland is facing one of its most severe trade challenges in decades after the United States implemented a 39 percent tariff on Swiss exports, a rate among the highest imposed under President Donald Trump’s ongoing overhaul of global trade rules.

Read More

Signs are mounting that the United States may be entering a “stagflation-lite” phase, as inflation edges higher while economic growth slows and labor market indicators weaken. Economists and market analysts warn that the combination of sticky prices, slowing job creation,

Read More

Gold futures in the United States surged to a record high on Friday after confirmation that country-specific import tariffs may apply to the most widely traded bullion size, the one-kilogram bar. The ruling, posted by the US Customs and Border

Read More

President Donald Trump signed an executive order on Thursday that could open the door for 401(k) retirement savers in the United States to invest in alternative assets such as private equity, real estate, and cryptocurrencies. While the move does not

Read More

AT&T CEO John Stankey has reaffirmed the company’s commitment to a five-day in-office work policy and a broader cultural overhaul aimed at positioning the 140-year-old telecom giant for long-term relevance. In a memo to managers obtained by the media outlets,

Read More

Apple has announced an expanded investment plan that raises its total U.S. commitment to 600 billion dollars over the next four years. This includes the launch of the American Manufacturing Program, a new initiative aimed at strengthening the domestic supply

Read More

The United States has announced a significant escalation in its trade measures against India, with President Donald Trump issuing an executive order to increase tariffs on Indian imports to 50 percent. The move, tied directly to India’s continued purchase of

Read More

Pfizer has raised its full-year adjusted earnings forecast for 2025, driven by cost-cutting measures and robust second-quarter performance that exceeded Wall Street expectations. The pharmaceutical giant now anticipates adjusted earnings per share between $2.90 and $3.10, up from its prior

Read More